Association of Community Cancer Centers to Honor Seven Cancer Programs with Innovator Awards at 35th National Oncology Conference
Hundreds of oncology professionals will gather in Phoenix, Arizona, to share best practices and creative approaches that address the most pressing issues facing cancer programs in communities around the country.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
